慢性肢体威胁性缺血:手术与腔内治疗的临床效果与资源利用系统综述
系统综述比较慢性肢体威胁性缺血(CLTI)手术与腔内治疗的临床效果和资源利用。共纳入17篇文献(5篇来自同一随机对照试验,12篇观察性研究)。随机对照试验显示手术第一年资源使用更多,但后续年份差异不显著;全因死亡率前2年倾向腔内治疗(aHR 1.27,95%CI 0.75-2.15),2年后倾向手术(aHR 0.34,95%CI 0.17-0.71)。观察性研究短期效果和资源利用倾向腔内治疗,但多数差异无统计学意义,长期死亡率多倾向手术。
要点
- 随机对照试验中手术第一年总住院日显著多于腔内治疗(46.14±53.87 vs 36.35±51.39,P<0.001)。
- 随机对照试验全因死亡率前2年腔内向(aHR 1.27,95%CI 0.75-2.15),2年后手术向(aHR 0.34,95%CI 0.17-0.71)。
- 观察性研究短期效果与资源利用多倾向腔内治疗,但多数差异无统计学意义。
核心结论
- CLTI手术与腔内治疗的临床效果和资源利用尚无确定性结论,需等待进行中的试验结果。
- 初始结局和资源利用倾向腔内干预,而长期结局倾向外科血运重建。
研究设计与样本
- 系统综述纳入比较CLTI手术与腔内治疗的随机对照试验和观察性研究。
- 检索获得4231条题录,17篇文献符合纳入标准,其中5篇来自同一随机对照试验,12篇为观察性研究。
主要发现
- 随机对照试验中,手术第一年总住院日显著多于血管成形术(46.14±53.87 vs 36.35±51.39,P<0.001),高依赖和重症监护病房天数亦然,但后续年份差异无统计学意义。
- 随机对照试验全因死亡率前2年倾向血管成形术但差异无统计学意义(aHR 1.27,95%CI 0.75-2.15),2年后倾向手术治疗(aHR 0.34,95%CI 0.17-0.71)。
- 观察性研究短期效果和资源利用倾向腔内治疗,但多数差异无统计学意义;长期结局混杂,死亡率一般倾向手术,但无法确定因果关系,因腔内治疗患者往往年龄更大、预期寿命可能更短。
临床怎么用
- CLTI血运重建决策需权衡时间 horizon:初始结局和资源利用倾向腔内治疗,长期结局倾向手术。
- 应结合患者年龄、预期寿命和资源条件个体化选择血运重建方式。
局限性
- 多数证据来自观察性研究,存在选择偏倚,腔内治疗患者年龄更大可能影响死亡率比较。
- 随机对照试验证据仅来自单一试验的5篇出版物。
- 临床效果和资源利用的确定性结论需等待进行中的试验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical effectiveness of surgical versus endovascular therapy for chronic limb-threatening ischemia (CLTI) continues to be debated, and the resources required for each therapy are unclear. METHODS: Systematic review of randomized controlled trials (RCTs) and observational studies comparing surgery with endovascular therapy for CLTI, which reported clinical effectiveness and resource utilization. Short-term and long-term clinical outcomes were examined. RESULTS: The search yielded 4,231 titles, of which 17 publications met our inclusion criteria. Five publications were all from 1 RCT, and 12 publications were observational studies. In the RCT, the surgical approach had greater resource use in the first year (total hospital days across all admissions for surgery versus angioplasty: 46.14 ± 53.87 vs. 36.35 ± 51.39; P < 0.001; also true for days in high-dependency and intensive therapy units), but differences were not statistically significant in subsequent years. All-cause mortality presented a nonsignificant difference favoring angioplasty in the first 2 years (adjusted hazard ratio [aHR], 1.27; 95% confidence interval [95% CI], 0.75-2.15), but after 2 years, it favored surgical treatment (aHR, 0.34; 95% CI, 0.17-0.71). The observational studies reported short-term effectiveness and resource utilization favoring endovascular therapy, but most differences were not statistically significant. Long-term outcomes were more mixed; in particular, mortality outcomes generally favored surgery, although concluding that cause and effect is not possible as endovascularly treated patients tended to be older and may have had a shorter life expectancy regardless of therapy. CONCLUSIONS: The clinical effectiveness and resource utilization of surgery compared with endovascular therapy for CLTI is not known with certainty and will not be known until ongoing trials report results. It is likely that findings will vary by the time horizon, where initial outcomes and utilization tend to favor endovascular interventions, but long-term outcomes favor surgical revascularization.
引用
- Lamaina M, Childers CP, Liu C, et al. Clinical Effectiveness and Resource Utilization of Surgery versus Endovascular Therapy for Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2020. PMID: 32439522. doi:10.1016/j.avsg.2020.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。